Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.


Discover how IQVIA is accelerating therapeutic innovation for a healthier world with our latest infographic. Learn about our significant contributions to scientific innovation, including the development of over 70% of all new FDA-approved drugs and involvement in 80% of genetic disease therapy approvals. Explore our expertise across various therapeutic areas such as oncology, hematology, dermatology, and more.
Accelerate your obesity trial timelines with solutions designed for rapid execution by leveraging our team of seasoned experts and advanced patient recruitment solutions.
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.